Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain

The aralar/AGC1 knockout (KO) mouse shows a drastic decrease in brain aspartate and N‐acetylaspartate levels and global hypomyelination, which are attributed to the lack of neuron‐produced NAA used by oligodendrocytes as precursor of myelin lipid synthesis. In addition, these mice have a gradual drop in brain glutamine synthesis. We show here that hypomyelination is more pronounced in gray than in white matter regions. We find a lack of neurofilament‐labelled processes in hypomyelinated fiber tracks from cerebral cortex but not from those of the cerebellar granule cell layer, which correspond to Purkinje neurons. Therefore, the impaired development or degeneration of neuronal processes in cerebral cortex is independent of hypomyelination. An increase in O4‐labelled, immature oligodendrocytes is observed in gray and white matter regions of the aralar KO brain, suggesting a block in maturation compatible with the lack of NAA supplied by neurons. However, no defects in oligodendrocyte maturation were observed in in‐vitro‐cultured mixed astroglial cultures. We conclude that the primary defect of pyramidal neurons in cerebral cortex is possibly associated with a progressive failure in glutamatergic neurotransmission and may be among the main causes of the pathology of aralar/AGC1 deficiency. © 2011 Wiley‐Liss, Inc.

[1]  Miguel Garzón,et al.  Brain Glutamine Synthesis Requires Neuronal-Born Aspartate as Amino Donor for Glial Glutamate Formation , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  D. Bok,et al.  Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination , 2010, Neurobiology of Disease.

[3]  D. Jacobowitz,et al.  Nuclear‐cytoplasmic localization of acetyl coenzyme a synthetase‐1 in the rat brain , 2010, The Journal of comparative neurology.

[4]  Daniela Calvetti,et al.  Energetics of Inhibition: Insights with a Computational Model of the Human GABAergic Neuron–Astrocyte Cellular Complex , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  N. Pattabiraman,et al.  Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS , 2010, Brain Research.

[6]  J. Buxbaum,et al.  Slc25a12 Disruption Alters Myelination and Neurofilaments: A Model for a Hypomyelination Syndrome and Childhood Neurodevelopmental Disorders , 2010, Biological Psychiatry.

[7]  T. Saheki,et al.  Low levels of citrin (SLC25A13) expression in adult mouse brain restricted to neuronal clusters , 2010, Journal of neuroscience research.

[8]  Klaus-Armin Nave,et al.  Myelination and the trophic support of long axons , 2010, Nature Reviews Neuroscience.

[9]  F. Sterky,et al.  AGC1 deficiency associated with global cerebral hypomyelination. , 2009, The New England journal of medicine.

[10]  R. Matalon,et al.  Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease , 2009, Journal of neuroscience research.

[11]  A. Munnich,et al.  Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts , 2009, Clinical genetics.

[12]  D. Attwell,et al.  The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes , 2009, Brain : a journal of neurology.

[13]  B. Barres,et al.  Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS , 2008, The Journal of Neuroscience.

[14]  K. Plate,et al.  Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.

[15]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[16]  T. Saheki,et al.  Role of aralar, the mitochondrial transporter of aspartate‐glutamate, in brain N‐acetylaspartate formation and Ca2+ signaling in neuronal mitochondria , 2007, Journal of neuroscience research.

[17]  T. Nabeshima,et al.  A Novel Molecule “Shati” Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference , 2007, The Journal of Neuroscience.

[18]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[19]  T. Speed,et al.  Functional Genomic Analysis of Oligodendrocyte Differentiation , 2006, The Journal of Neuroscience.

[20]  H. Büssow,et al.  Oligodendrocyte‐specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT‐deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level , 2005, Glia.

[21]  T. Saheki,et al.  Reduced N-Acetylaspartate Levels in Mice Lacking Aralar, a Brain- and Muscle-type Mitochondrial Aspartate-glutamate Carrier* , 2005, Journal of Biological Chemistry.

[22]  Peter J. Brophy,et al.  Mechanisms of axon ensheathment and myelin growth , 2005, Nature Reviews Neuroscience.

[23]  J. Moffett,et al.  Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Munnich,et al.  Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. , 2005, American journal of human genetics.

[25]  B. Popko,et al.  Galactolipids are molecular determinants of myelin development and axo-glial organization. , 2002, Biochimica et biophysica acta.

[26]  B. Trapp,et al.  N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.

[27]  R. Ledeen,et al.  Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.

[28]  D. Rowitch,et al.  Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives , 2001, International Journal of Developmental Neuroscience.

[29]  V. Ganapathy,et al.  Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. , 2000, The Journal of pharmacology and experimental therapeutics.

[30]  R Reynolds,et al.  NG2‐expressing cells in the central nervous system: Are they oligodendroglial progenitors? , 2000, Journal of neuroscience research.

[31]  T. Serikawa,et al.  Accumulation of N‐Acetyl‐L‐Aspartate in the Brain of the Tremor Rat, a Mutant Exhibiting Absence‐Like Seizure and Spongiform Degeneration in the Central Nervous System , 2000, Journal of neurochemistry.

[32]  B. Popko,et al.  Effects of galactolipid elimination on oligodendrocyte development and myelination , 2000, Glia.

[33]  J. Kamholz,et al.  GFAP‐positive and myelin marker‐positive glia in normal and pathologic environments , 2000, Journal of neuroscience research.

[34]  S. Bluml In VivoQuantitation of Cerebral Metabolite Concentrations Using Natural Abundance13C MRS at 1.5 T , 1999 .

[35]  B. Popko,et al.  Demyelination and altered expression of myelin‐associated glycoprotein isoforms in the central nervous system of galactolipid‐deficient mice , 1998, Journal of neuroscience research.

[36]  M. Berry,et al.  The relationship between developing oligodendrocyte units and maturing axons during myelinogenesis in the anterior medullary velum of neonatal rats , 1997, Journal of neurocytology.

[37]  A. Bosio,et al.  Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Blight,et al.  Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability , 1996, Cell.

[39]  M. Namboodiri,et al.  N-acetylaspartate as an acetyl source in the nervous system. , 1995, Brain research. Molecular brain research.

[40]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  M. Schachner,et al.  Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. , 1981, Developmental biology.

[42]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.

[43]  K. Lanoue,et al.  Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. , 1974, The Journal of biological chemistry.

[44]  P. Courtoy,et al.  Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. , 2009, The Biochemical journal.

[45]  Beatriz Pardo,et al.  Mitochondrial transporters as novel targets for intracellular calcium signaling. , 2007, Physiological reviews.